Product Categories
| Country: | China |
|---|---|
| Tel: | +86-13347807150 |
| Mobile: | +86-13347807150 |
| E-mail: | support@tgpeptide.com |
| QQ: | 511774137 |
| Skype: | Chat Now! |
| Address: | Room 1204, Building F, No. 22 Tiansheng Road, Jiangbei New Area, Nanjing |
|
Nanjing TGpeptide Biotechnology Co.,Ltd.("TGpeptide" hereafter), who is founded in 2019, located at Jiangbei New Material Industrial Park, is a professional enterprise enageged in researching, developing, manufacturing and sales of peptide, antibody and protein products and their technologies. TGpeptide got strong support and funded by government from the beginning when TGpeptide was founded. Dr. Wu, the founder and director of TGpeptide, was graduated from Georgia State University at 2011. Dr Wu engaged in peptide industrial research since he came back to China at 2012. Dr. Wu gained many honors during the research these years including "Progress Awards for Peptide Research and Bulk Manufacturing II", "Scarce Talent of Lanzhou" at 2013 etc.
|
|
| Product Name | MF | CAS | Details |
|---|
| Neuropeptide Y (porcine) | C190H286N54O58 | 83589-17-7 | Details |
| (Ala31,Aib32)-Neuropeptide Y (porcine) | C187H281N55O56 | 313988-59-9 | Details |
| (Leu31,Pro34)-Neuropeptide Y (porcine) | C190H286N54O56 | 125580-28-1 | Details |
| (Pro34)-Neuropeptide Y (porcine) | C190H286N54O56 | 128768-54-7 | Details |
| (D-Trp32)-Neuropeptide Y (porcine) | C197H290N56O56 | 153549-78-1 | Details |
| Anxiety Peptide | C81H138N24O29 | 95237-86-8 | Details |
| α Bag Cell Peptide (1-9) | C53H83N15O12 | 87549-52-8 | Details |
| β-Bag Cell Peptide (Aplysia californica) | C33H53N13O6 | 109024-47-7 | Details |
| Bradykinin-Like Neuropeptide (Aplysia californica) | C53H98N24O14S | 165174-60-7 | Details |
| Neuropeptide W-23 (human) | C119H183N35O28S | 383415-79-0 | Details |
| Biotinyl-Neuropeptide W-23 (human) | C129H197N37O30S2 | 1815618-09-7 | Details |
| Neuropeptide W-23 (rat) | C119H183N35O29S | 383415-89-2 | Details |
| Neuropeptide W-30 (human) | C165H249N49O37S | 383415-80-3 | Details |
| Neuropeptide W-30 (rat) | C165H249N49O38S | 383415-90-5 | Details |
| Nociceptin (1-13) amide | C61H100N22O15 | 178064-02-3 | Details |
| (Phe1-psi(CH2NH)Gly2)-Nociceptin (1-13) amide | C61H102N22O14 | 213130-17-7 | Details |
| Nociceptin | C79H129N27O22 | 170713-75-4 | Details |
| Peptide Lv (rat) | 1872441-58-1 | Details |
| H-Phe-Gly-Gly-Phe-OH | C22H26N4O5 | 40204-87-3 | Details |
| Prokineticin 2 Isoform 2 (human) | 423206-00-2 | Details |
| RF9 | C26H38N6O3 | 876310-60-0 | Details |
| Scyliorhinin I | C59H87N13O13S | 103425-21-4 | Details |
| Secretoneurin (mouse, rat) | C28H33NO7 | 149146-12-3 | Details |
| H-Tyr-Gln-Ser-Leu-Arg-Trp-NH2 | C40H58N12O9 | 328074-18-6 | Details |
| [Nphe1]Nociceptin(1-13)NH2 | C61H100N22O15 | 267234-08-2 | Details |
| Kinetensin | C56H85N17O11 | 103131-69-7 | Details |
| Neurotensin | C78H121N21O20 | 55508-42-4 | Details |
| (Trp11)-Neurotensin | C80H122N22O19 | 75644-95-0 | Details |
| (D-Trp11)-Neurotensin | C80H122N22O19 | 100929-52-0 | Details |
| (D-Tyr11)-Neurotensin | C78H121N21O20 | 64088-62-6 | Details |
| Neurotensin (1-6) | C35H52N8O12 | 87620-09-5 | Details |
| Neurotensin (1-8) | C46H71N13O14 | 80887-44-1 | Details |
| Buccalin | C45H72N12O15S | 116786-35-7 | Details |
| Cerebellin | C69H113N23O23 | 94071-26-8 | Details |
| (Des-Ser1)-Cerebellin | C66H108N22O21 | 94245-80-4 | Details |
| Cortistatin-17 (human) | C96H139N27O24S3 | 189450-19-9 | Details |
| Delta-Sleep Inducing Peptide | C35H48N10O15 | 62568-57-4 | Details |
| (Asn5)-Delta-Sleep Inducing Peptide | C35H49N11O14 | 80064-67-1 | Details |
| (β-Asp5)-Delta-Sleep Inducing Peptide | C35H48N10O15 | 82602-88-8 | Details |
| Eledoisin | C54H85N13O15S | 69-25-0 | Details |
| Head activator (7-11) | C32H54N6O6 | 103404-59-7 | Details |
| Head activator | C54H84N12O14 | 79943-68-3 | Details |
| He-LWamide II | C35H53N9O6 | 198995-08-3 | Details |
| Hemokinin 1 (human) | C54H84N14O14S | 491851-53-7 | Details |
| Hemokinin 1 (mouse, rat) | C61H100N22O15S | 208041-90-1 | Details |
| Hippocampal Cholinergic Neurostimulating Peptide | C53H79N13O17 | 140158-49-2 | Details |
| Leech Osmoregulatory Factor | C50H67N9O14 | 175413-77-1 | Details |
| LymnaDFamide-1 | C68H96N18O22 | 148596-98-9 | Details |
| Metamorphosin A | C34H47N9O8 | 157622-03-2 | Details |
| (Des-Bromo)-Neuropeptide B (1-23) (human) | C107H162N30O30 | 434897-64-0 | Details |
| Neuropeptide γ | C99H158N34O29S | 114882-65-4 | Details |
| Neuropeptide FF | C54H76N14O10 | 99566-27-5 | Details |
| (D-Tyr1,N-Me-Phe3)-Neuropeptide FF | C55H78N14O11 | 145274-93-7 | Details |
| Neuropeptide GE | C81H125N23O34 | 134748-04-2 | Details |
| Neuropeptide K (human, porcine, rat) | C8H11NO4 | 96827-05-3 | Details |
| Neuropeptide S (human) | C93H155N31O28S | 412938-67-1 | Details |
| Neuropeptide S (1-10) (human) | C42H68N14O14S | 904910-39-0 | Details |
| Neuropeptide S (rat) | C95H160N34O27 | 412938-75-1 | Details |
| Neuropeptide Y (13-36) (porcine) | C135H209N41O36 | 113662-54-7 | Details |
| Pancreatic Polypeptide (1-17)-(Ala31,Aib32)-Neuropeptide Y (18-36) (human) | 313988-70-4 | Details |
| Neuropeptide Y (18-36) | C112H174N36O27 | 114495-97-5 | Details |
| Neuropeptide Y (22-36) | C85H139N29O21 | 119019-65-7 | Details |
| Acetyl-(Leu28.31)-Neuropeptide Y (24-36) | C81H131N27O19 | 155709-24-3 | Details |
| Tyr-Lys-Gly-(Cyclo(Glu26-Lys29),Pro34)-Neuropeptide Y (25-36) | C91H145N27O20 | 185032-24-0 | Details |
| ((Cys31,Nva34)-Neuropeptide Y (27-36))2 | C116H186N36O28S2 | 172997-92-1 | Details |
| (Pro30,Tyr32,Leu34)-Neuropeptide Y (28-36) | C57H91N17O12 | 161650-01-7 | Details |
| (His32,Leu34)-Neuropeptide Y (32-36) | C33H54N14O6 | 168916-68-5 | Details |
| (Gly1,Ser3.22,Gln4.34,Thr6,Arg19,Tyr21,Ala23.31,Aib32)-Pancreatic Polypeptide (human) | C183H281N57O54S2 | 313988-89-5 | Details |
| PYX-1 | C70H105Cl2N19O16 | 140842-17-7 | Details |
| Spaglumic acid | C11H16N2O8 | 3106-85-2 | Details |
| β-Spaglumic acid | C11H16N2O8 | 4910-46-7 | Details |
| Anthopleurin-A | C215H326N62O67S6 | 60880-63-9 | Details |
| Antho-Rfamide | C22H32N8O5 | 107535-01-3 | Details |
| Antho-RPamide III | C42H68N12O9 | 763074-36-8 | Details |
| Neurotensin (8-13) | C38H64N12O8 | 60482-95-3 | Details |
| Acetyl-Neurotensin (8-13) | C40H66N12O9 | 74853-69-3 | Details |
| Neurotensin (9-13) | C32H52N8O7 | 60482-96-4 | Details |
| Neuropeptide Y (3-36) (human, rat) | C175H269N53O54S1 | 150138-78-6 | Details |
| Neuropeptide Y (3-36) (porcine) | C176H271N53O54 | 143863-88-1 | Details |
| Neuropeptide Y (13-36) (human, rat) | C134H207N41O36S | 122341-40-6 | Details |
| (Leu31,Pro34)-Neuropeptide Y (13-36) (human, rat) | C134H206N40O35S | 302798-54-5 | Details |
| H-Glu(Gly-Gly-OH)-OH | C9H15N3O6 | 13640-39-6 | Details |
| Ophthalmic Acid | C11H19N3O6 | 495-27-2 | Details |
| BAM-12P | C62H97N21O16S | 75513-71-2 | Details |
| BAM-22P | C130H184N38O31S2 | 76622-26-9 | Details |
| Brain Injury Derived Neurotrophic Peptide | C62H102N18O18 | 148330-12-5 | Details |
| (Des-Gly)-Ophthalmic acid | C9H16N2O5 | 16869-42-4 | Details |
| (Des-Glu)-Ophthalmic acid | C6H12N2O3 | 16305-80-9 | Details |
| Saposin C (15-32) (rat) | C89H155N21O29 | 175922-65-3 | Details |
| BAM-12P (7-12) | C29H52N12O9 | 321940-50-5 | Details |
| Neuropeptide Y (1-24) amide (human, rat) | C116H170N30O40S | 131448-51-6 | Details |
| JMV 1296 | C39H59N11O8 | 160662-16-8 | Details |
| (D-Tyr27.36,D-Thr32)-Neuropeptide Y (27-36) | C61H99N19O15 | 163887-48-7 | Details |
| Boc-(Lys9)-Neurotensin (9-13)-methyl ester | C38H62N6O9 | 89545-20-0 | Details |
| Neurotensin (1-11) | C66H99N19O18 | 74032-89-6 | Details |
| Acetalin-2 | C44H66N14O7S2 | 152274-66-3 | Details |
| JMV 449 | C38H66N8O7 | 139026-66-7 | Details |
| Neuropeptide Y (2-36) (human, rat) | 123139-39-9 | Details |
| (Cys2)-Neuropeptide Y (1-4)-8-aminooctanoyl-(D-Cys27)-Neuropeptide Y (25-32) | C96H158N32O23S2 | 128806-04-2 | Details |
| (Dab9)-Neurotensin (8-13) | C36H60N10O8 | 166824-25-5 | Details |
| Product Total： Product Page： | ||||
| 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 | ||||